The Russell 2000 hit an all-time high of 2,888.62 on May 6, 2026. The iShares Russell 2000 ETF (IWM) is up 31% over the past 12 months. That is not noise. That is the longest small-cap outperformance streak since 1996, and it has real structural drivers behind it.
This is not a story about one hot sector or a short squeeze. It is a sector rotation that has been building since late 2025, and the mechanics behind it are still active. Here is what is driving it, what the risks are, and which Stoxcraft-rated names are positioned to hold up inside it.
Why the Russell 2000 is leading the market in 2026
Small caps don't lead without a reason. Three forces hit at the same time in late 2025 and early 2026, and they all pushed in the same direction.
How Fed rate cuts gave small caps their biggest tailwind in years
The Federal Reserve cut rates three times in late 2025, bringing the target range to 3.50-3.75%. That might sound like a small move. For the Russell 2000 index, it was enormous.
About 40% of the debt held by Russell 2000 companies is floating-rate, compared to under 10% for S&P 500 companies. When rates drop, large caps barely notice. Small caps feel it immediately in their borrowing costs. Lower expected rates cut the cost of that floating-rate debt directly, expanding margins for hundreds of domestically focused businesses that couldn't absorb the "higher for longer" environment.
That relief, combined with legislative changes in 2025 that restored immediate R&D expensing and 100% bonus depreciation, made small-cap cash flow math look a lot more attractive than it had in years.
How a 31% valuation discount made the rotation inevitable
At the start of 2026, the Russell 2000 was trading at roughly 18x forward earnings. The S&P 500 was near 26x. That gap had reached a multi-decade extreme, and the S&P Small Cap 600 was sitting at a 31% discount to the S&P 500 on forward earnings.
Historically, small-cap stocks command a premium over large caps because of higher growth potential. Years of high rates had compressed their multiples to levels not seen since the dot-com era. When the Fed pivoted, the valuation gap started closing. Analysts are calling it the "Great Convergence." Small-cap earnings are projected to grow 17-18% in back-to-back forward years. The rerating had data behind it.
How to tell the real leaders from the fragile names
Not every Russell 2000 stock benefits from this environment equally. The rotation rewards quality. It punishes fragility. And a meaningful chunk of the index falls into the fragile category.
An estimated 40-46% of Russell 2000 companies can't cover their interest expense with operating profits. They survive by rolling over debt. They needed low rates and stable conditions to stay alive. As long as rates stay lower than their 2023-2024 peaks, that pressure is manageable. If inflation resurges and the Fed pauses, that floating-rate advantage reverses fast.
Small-cap companies also face a significant debt maturity wall this cycle, with much of it originally issued at 1-2% rates now facing refinancing near 6.5%. The stocks that don't depend on cheap debt to survive are the ones worth owning through a rotation that still has risk inside it.
Watch high-yield credit spreads. When they're tight, small-cap refinancing math works. When they widen, the weaker names crack fast. Cboe Global Markets (CBOE) actually provides the infrastructure behind much of the volatility and hedging activity that signals stress in real time.
Three Stoxcraft-rated small-cap names built for this environment
Filtering the Russell 2000 for quality means looking past the headline index number. The three names below score well on fundamentals, carry lower debt risk than their peers, and have real earnings momentum behind their scores. All three are confirmed in the Stoxcraft screener.
Cboe Global Markets (CBOE): the exchange that earns more when markets reprice
Cboe Global Markets (CBOE) is one of the rare businesses that benefits from the same volatility that pressures the rest of the Russell 2000 index. When markets reprice, hedging demand goes up. Cboe owns the infrastructure that handles it.
Q1 2026 delivered record results. Net revenue hit $729M, up 29% year over year. Adjusted diluted EPS rose 48% to $3.70, beating analyst estimates by $0.33. Derivatives revenue grew 32%, driven by index options, and SPX options posted a quarterly record with average daily volume up 34% to 4.9M contracts. Management raised 2026 organic net revenue growth guidance to "low double-digit to mid-teens," up from "mid single-digit." The Health Score profile reflects genuinely low leverage and strong recurring revenue. That revenue is mostly driven by volume, not by economic conditions. Volatility doesn't hurt Cboe. It helps.
The Risk Score is lower than most financials of comparable size, because revenue is structurally decoupled from credit cycles. The entry signal reflects an exchange business trading near its 52-week high after a strong earnings beat. Cboe's analyst consensus is broadly bullish.
Curtiss-Wright (CW): defense compounding with a record $4.3B backlog
Curtiss-Wright Corporation (CW) is an aerospace and defense supplier whose revenue visibility doesn't depend on macro tailwinds. It depends on long-term defense contracts. That distinction matters a lot in an environment where small-cap fundamentals are being tested.
Q1 2026 was strong. Sales rose 13% to $913.7M, and adjusted EPS grew 23% to $3.48, both beating analyst estimates. New orders climbed 16% to about $1.2B, producing a 1.3x book-to-bill. Backlog reached $4.3B, up 5% from December 2025, with 90% expected to convert to revenue within 36 months. Management raised full-year 2026 guidance to $3.77B in revenue and $15.10 in adjusted EPS at the midpoint. Free cash flow guidance is $580-600M with over 105% conversion.
The Health Score reflects the strength of that backlog and margin discipline. Operating margin was 17.6%, up 100 basis points. The free cash flow conversion above 100% is a signal that earnings quality is high, not accounting-driven. The beta is low relative to the defense sector. The Risk Score reflects a business where revenue is locked in years ahead.
The geopolitical environment expanding defense budgets globally is structural, not cyclical. CW earns through defense contracts whether the broader small-cap trade is in favor or not.
Perdoceo Education (PRDO): cash-heavy with a valuation gap the market hasn't closed
Perdoceo Education (PRDO) is a consumer discretionary name that doesn't fit the typical mold. It's a postsecondary education company with $643.5M in cash, restricted cash, and short-term investments on its balance sheet, generating cash flow that most sector peers can't match.
Full-year 2025 revenue grew 24.2% to $846.1M. Operating cash flow hit $225.2M. Adjusted EPS guidance for 2026 is $2.97-$3.12, reflecting continued growth from higher enrollment and its 2024 USAHS acquisition. Total student enrollments grew 7.3% to 44,400 at year-end 2025. The business isn't dependent on cheap debt. It generates cash and holds it.
The Health Score is driven by that exceptional cash position and consistent free cash flow generation. PRDO's price-to-cash-flow sits well below the consumer discretionary sector average, reflecting a valuation gap that hasn't closed despite solid execution. The analyst consensus points toward continued upside with a moderate buy signal. The Risk Score is low for its size, reflecting limited leverage and low drawdown exposure relative to volatile small-cap peers.
What the rotation still needs to sustain itself
The structural case for small caps is intact. The valuation gap is real. The rate environment is supportive. Small-cap earnings growth projections for the next two years are among the strongest in the market.
Three things can accelerate or slow this rotation. First, interest rates: any inflation resurgence that forces the Fed to pause would directly hit the floating-rate debt advantage. Second, high-yield credit spreads: as long as they're tight, refinancing works for the weaker names. When they widen, the fragile tier cracks. Third, earnings delivery: the rotation is no longer just a valuation story. Small caps need to prove the earnings growth projections are real.
CBOE, CW, and PRDO all sit on the right side of those tests. They don't depend on perfect macro conditions to stay solvent. That is why their Stoxcraft profiles hold up when the headline index comes under pressure.
The diversification argument for small caps is straightforward: you don't need to abandon the asset class to manage the risk inside it. You need to own the names that don't depend on cheap oil and cheap debt to survive. The rotation is real. The quality filter is what makes it durable.
For more on how the broader 2026 market forces are shaping stock-picking, see the 5 biggest forces shaping the stock market in 2026.
